Rational Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.88M | Buy |
3,236
+1,669
| +107% | +$1.71M | 0.36% | 56 |
|
|
2026
Q1 | $1.44M | Sell |
1,567
-1,358
| -46% | -$1.38M | 0.15% | 72 |
|
|
2025
Q4 | $3.14M | Buy |
2,925
+1,749
| +149% | +$1.67M | 0.32% | 55 |
|
|
2025
Q3 | $897K | Sell |
1,176
-1,608
| -58% | -$1.2M | 0.09% | 86 |
|
|
2025
Q2 | $2.17M | Buy |
2,784
+2,361
| +558% | +$1.83M | 0.22% | 65 |
|
|
2025
Q1 | $349K | Sell |
423
-285
| -40% | -$237K | 0.04% | 110 |
|
|
2024
Q4 | $547K | Sell |
708
-2,892
| -80% | -$2.39M | 0.05% | 94 |
|
|
2024
Q3 | $3.19M | Sell |
3,600
-409
| -10% | -$368K | 0.31% | 50 |
|
|
2024
Q2 | $3.63M | Buy |
4,009
+259
| +7% | +$207K | 0.35% | 39 |
|
|
2024
Q1 | $2.92M | Buy |
+3,750
| New | +$2.67M | 0.27% | 50 |
|
|
2023
Q4 | – | Sell |
-3,400
| Closed | -$1.83M | – | 244 |
|
|
2023
Q3 | $1.83M | Sell |
3,400
-1,000
| -23% | -$515K | 0.17% | 65 |
|
|
2023
Q2 | $2.06M | Sell |
4,400
-1,200
| -21% | -$503K | 0.17% | 59 |
|
|
2023
Q1 | $1.92M | Buy |
5,600
+3,515
| +169% | +$1.19M | 0.16% | 58 |
|
|
2022
Q4 | $763K | Sell |
2,085
-446
| -18% | -$158K | 0.06% | 80 |
|
|
2022
Q3 | $818K | Buy |
+2,531
| New | +$802K | 0.06% | 85 |
|
|
2020
Q4 | – | Sell |
-363
| Closed | -$53K | – | 439 |
|
|
2020
Q3 | $53K | Buy |
363
+344
| +1,811% | +$53.2K | 0.02% | 189 |
|
|
2020
Q2 | $3K | Buy |
+19
| New | +$2.92K | ﹤0.01% | 459 |
|
|
2020
Q1 | – | Sell |
-23
| Closed | -$3K | – | 365 |
|
|
2019
Q4 | $3K | Sell |
23
-125
| -84% | -$14.5K | ﹤0.01% | 510 |
|
|
2019
Q3 | $17K | Sell |
148
-1,144
| -89% | -$127K | 0.01% | 468 |
|
|
2019
Q2 | $143K | Sell |
1,292
-28,340
| -96% | -$3.34M | 0.05% | 261 |
|
|
2019
Q1 | $3.85M | Buy |
29,632
+10,132
| +52% | +$1.23M | 1.04% | 19 |
|
|
2018
Q4 | $2.26M | Buy |
19,500
+5,150
| +36% | +$575K | 0.7% | 39 |
|
|
2018
Q3 | $1.54M | Buy |
14,350
+12,738
| +790% | +$1.27M | 0.37% | 74 |
|
|
2018
Q2 | $138K | Sell |
1,612
-7,702
| -83% | -$633K | 0.06% | 221 |
|
|
2018
Q1 | $720K | Buy |
9,314
+6,314
| +210% | +$508K | 0.34% | 109 |
|
|
2017
Q4 | $253K | Sell |
3,000
-600
| -17% | -$51.1K | 0.13% | 176 |
|
|
2017
Q3 | $308K | Hold |
3,600
| – | – | 0.16% | 134 |
|
|
2017
Q2 | $296K | Buy |
+3,600
| New | +$294K | 0.18% | 137 |
|
|
2015
Q3 | $21K | Hold |
246
| – | – | 0.01% | 285 |
|
|
2015
Q2 | $21K | Hold |
246
| – | – | 0.01% | 285 |
|
|
2015
Q1 | $18K | Sell |
246
-164
| -40% | -$11.7K | ﹤0.01% | 297 |
|
|
2014
Q4 | $28K | Buy |
+410
| New | +$27.7K | 0.01% | 320 |
|
|
2013
Q4 | $5.52M | Buy |
108,215
+64,359
| +147% | +$3.22M | 0.47% | 59 |
|
|
2013
Q3 | $2.21M | Buy |
43,856
+4,400
| +11% | +$230K | 0.17% | 194 |
|
|
2013
Q2 | $1.94M | Buy |
+39,456
| New | +$2.15M | 0.16% | 212 |
|
Other funds holding LLY
SC
ONB
GIM
Rational Advisors's LLY Position: Q2 2026 in Review
Rational Advisors increased its Eli Lilly (LLY) stake by 107% in Q2 2026, buying an estimated $1.71M and bringing the position to 3,236 shares worth $3.88M. The position accounts for 0.36% of the portfolio, ranked #56.
Rational Advisors first reported a position in LLY in Q2 2013 and has held it in 35 quarters since. The position peaked at $5.52M in Q4 2013. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Rational Advisors held 3,236 shares of Eli Lilly worth $3.88M as of Q2 2026.
- Rational Advisors bought 1,669 Eli Lilly shares in Q2 2026, an estimated $1.71M.
- Eli Lilly made up 0.36% of Rational Advisors's portfolio in Q2 2026, its #56 holding.
- Rational Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 35 quarters since.
- Rational Advisors's Eli Lilly position peaked at $5.52M in Q4 2013.
- 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Rational Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.